期刊文献+

定量动态增强磁共振技术的影响因素分析 被引量:4

Analysis of the main factors affecting quantitative dynamic contrast-enhanced MR imaging
下载PDF
导出
摘要 动态增强磁共振成像(dynamic contrast-enhanced MRI,DCE-MRI)基于快速T1WI,行多期动态增强扫描,获取感兴趣区时间-信号强度曲线,再通过药代动力学模型分析,得到反映组织灌注及血管渗透性的定量参数,已应用于肿瘤诊断、疗效评价、预后评估。作者针对影响DCE-MRI结果的主要因素:扫描方案、动脉输入函数(arterial input functions,AIF)、运动位移、药代动力学模型,进行系统评价,通过提高DCE-MRI参数的可重复性和准确性,为临床应用提供帮助。 DCE-MRI is based on the serial acquisition of the fast T1W1. Through multi-phase contrast enhanced scanning, the time-signal intensity curve of the region- of-interest (ROI) can be acquired. Meanwhile, the quantitative parameters reflecting tissue perfusion and vascular permeability are obtained by selecting the proper pharmacokinetic model. This method has been widely applied in many clinical aspects, including tumor diagnosis, assessment of therapeutic response and prognostic evaluation. In this paper, we conducted a systematic review focused on main factors that may influence DCE-MRI outcomes. These factors include scanning protocol, arterial input functions (AIF), the motion displacement and the pharmacokinetic models. Optimizing these main factors may improve the reproducibility and accuracy of the DCE-MRI results.
出处 《磁共振成像》 CAS CSCD 2017年第1期76-80,共5页 Chinese Journal of Magnetic Resonance Imaging
基金 陕西省社会发展科技攻关项目(2015SF175)~~
关键词 磁共振成像 动态增强 定量分析 Magnetic resonance imaging Dynamic contrast-enhanced Quantitative analysis
  • 相关文献

参考文献4

二级参考文献73

  • 1赵京龙,张贵祥.动态增强MR成像在肿瘤血管生成功能成像中的应用[J].中国医学影像技术,2004,20(8):1293-1295. 被引量:7
  • 2卢光明,杨刚,张福琛,沈复兴,王昌新.动态增强MRI诊断垂体微腺瘤的研[J].中华放射学杂志,1996,30(5):329-332. 被引量:39
  • 3刘鹏飞,那婧,王晓睿,王媛,戴险峰.MR灌注成像在鉴别脑胶质瘤放疗后坏死与肿瘤复发中的应用[J].临床放射学杂志,2007,26(11):1080-1083. 被引量:11
  • 4Runge VM, Clanton JA, Herzer WA, et al. Intravascular contrast agents suitable for magnetic resonance imaging[J]. Radiology, 1984,153(1): 171-176.
  • 5Dujardin MI, Sourbron SP, Chaskis C, et al. Quantification of cerebral tumour blood flow and permeability with T,- weighted dynamic contrast enhanced MRI: a feasibility study [J].J Neuroradiol, 2012, 39(4):227-235.
  • 6Johnson G, Wetzel SG, Cha S, et al. Measuring blood volume and vascular transfer constant from dynamic, T(2)" - weighted contrast -enhancet~lRI[J].MagnResonMed,200431 (5):961-968.
  • 7Agner SC, Rosen MA, Englander S, et al. Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study[J].Radiology, 2014, 272(1):91-99.
  • 8Nci C. MR workshop on translational research in cancer: recommendations for MR measurement methods at 1.5-Tesla and endpoints for use in phase 1/2a trials of anti- cancer therapeutics affecting tumor vascular function[R]. Maryland: National Cancer Institute, National Institutes of Health, 2008:1-10.
  • 9Tofts PS, Kermode AG. Measurement of the blood- brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts[J].Magn Reson Med, 1991, 17(2):357-367.
  • 10van Lin EN, Fiitterer JJ, Heijmink SW, et al. IMRT boost dose planning on dominant intraprostatic lesions: gold marker- based three-dimensional fusion of CT with dynamic contrast- enhanced and 1H-spectroscopic MRI[J]. Int J Radiat Oncol Biol Phys,2006,65(1):291-303.

共引文献90

同被引文献38

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部